Omicron News and Research

RSS

Point-of-care rapid diagnostics for detecting SARS-CoV-2 in exhaled breath

Researchers developed a rapid, non-invasive, point-of-care platform for the direct detection of SARS-CoV-2 in exhaled breath.

3 Aug 2023

Identifying risks and solutions: study uncovers correlates of protection against COVID-19

Study identified correlates of protection healthy individuals who have received three doses of Pfizer- BNT162b2 vaccine.

2 Aug 2023

Using wastewater monitoring to assess patterns in community transmission of COVID-19

Researchers develop and test a novel algorithm to detect COVID-19 surges before they occur.

2 Aug 2023

Analytical and clinical evaluation of antigen-based rapid diagnostic tests against the most encountered SARS-CoV-2 variants

A recent study has assessed the sensitivity of Ag-RDTs against the most prevalent BA.5 Omicron sub-lineage.

2 Aug 2023

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

In a recent study, researchers working at Ohio State University in the United States of America (USA) developed an intranasal subunit vaccine.

2 Aug 2023

Three doses of mRNA vaccine provide good protection for vulnerable people

Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine.

1 Aug 2023

New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody

Researchers developed potent monoclonal antibodies from a severe acute respiratory syndrome coronavirus (SARS-CoV) survivor.

1 Aug 2023

Are wastewater surveillance metrics associated with high community case and hospitalization rates of COVID-19 across US counties?

Study aimed to understand whether the use of at-home COVID-19 tests impacted the determination of community-level incidence.

1 Aug 2023

Investigating the neurological effects of SARS-CoV-2: anosmia and neuroinvasion as separate phenomena

A group of researchers investigated the neurotropic potential of SARS-CoV-2 and its variants by studying their ability to invade the brain through the olfactory pathway in hamsters.

1 Aug 2023

New device can detect COVID-19 in less than a minute

Benjamin Sumlin, PhD, a senior scientist at Washington University in St. Louis, blows into a device designed by researchers at the university. The device — a breath test that uses a biosensor — could become a tool for use in doctors' offices to quickly diagnose people infected with the virus that causes COVID-19.

1 Aug 2023

The incidence of diabetes following mRNA, inactivated COVID-19 vaccines, and after SARS-CoV-2 infection

Researchers evaluate the risk of new-onset diabetes linked with COVID-19 vaccination and infection.

31 Jul 2023

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

Study investigated if patients with systemic autoimmune rheumatic diseases (SARDs) have a reduced immunological response.

27 Jul 2023

Study provides valuable insights into the UV susceptibility of SARS-CoV-2 omicron variants

The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its new variants has created a need for effective disinfection technologies to protect against harmful pathogens.

27 Jul 2023

Heterologous booster schedules are associated with increased protection against severe, omicron related COVID-19 outcomes

Study compared different coronavirus disease 2019 (COVID-19) vaccination regimens.

26 Jul 2023

Widespread vaccination needed to protect adults from serious and moderate COVID-19 disease

An analysis of real-world data from more than 1.2 million patients from health systems in four geographically dispersed states -- Indiana, Oregon, Texas and Utah -- conducted by the U.S. Centers for Disease Control and Prevention's VISION Network, has determined both the number of adults needed to be vaccinated to prevent one COVID-19 associated hospitalization and the number needed to be vaccinated to prevent one COVID-19 associated emergency department (ED) visit.

25 Jul 2023

Omicron News and Research

Point-of-care rapid diagnostics for detecting SARS-CoV-2 in exhaled breath

Identifying risks and solutions: study uncovers correlates of protection against COVID-19

Using wastewater monitoring to assess patterns in community transmission of COVID-19

Analytical and clinical evaluation of antigen-based rapid diagnostic tests against the most encountered SARS-CoV-2 variants

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

Three doses of mRNA vaccine provide good protection for vulnerable people

New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody

Are wastewater surveillance metrics associated with high community case and hospitalization rates of COVID-19 across US counties?

Investigating the neurological effects of SARS-CoV-2: anosmia and neuroinvasion as separate phenomena

New device can detect COVID-19 in less than a minute

The incidence of diabetes following mRNA, inactivated COVID-19 vaccines, and after SARS-CoV-2 infection

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

Study provides valuable insights into the UV susceptibility of SARS-CoV-2 omicron variants

Heterologous booster schedules are associated with increased protection against severe, omicron related COVID-19 outcomes

Widespread vaccination needed to protect adults from serious and moderate COVID-19 disease

Characterizing the concentration and binding affinity of WT–induced antibodies against the Omicron subvariant BA.1

Flu and COVID-19 report offers latest surveillance data and public health advice

A model-based approach to estimating vaccine effectiveness against SARS-CoV-2 variants of concern

Trypsin and anaerobic bacteria boost SARS-CoV-2 Delta variant infectivity: oral hygiene key to prevention

Comparing severe outcome risks of SARS-CoV-2 Omicron BA.2.75, BQ.1, BA.4.6 to BA.5

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News